Provider
Erectile Dysfunction - Phosphodiesterase Type 5 Inhibitors, Topical Prostaglandin - Commercial
Quantity Limit
Program effective Date: Nov 01, 2025
Documents & Forms Results
Displaying 41 - 50 of 3585 results
Provider
Compounded Medications - Commercial
Formulary Exception, Coverage Exception
Program effective Date: Nov 01, 2025
Provider
Vowst (fecal microbiota spores, live-brpk) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Provider
Vowst (fecal microbiota spores, live-brpk) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Provider
Rho Kinase Inhibitor - Commercial
Quantity Limit
Program effective Date: Nov 01, 2025
Provider
Furoscix (furosemide) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Provider
Tarpeyo - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Provider
OTC COVID-19 At-Home Test - Medicaid
Quantity Limit
Program effective Date: Nov 01, 2025
Provider
Gonadotropin Hormones - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Provider
Gattex (teduglutide) - Commercial
Prior Authorization
Program effective Date: Nov 01, 2025